11:12 AM
Mar 07, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Amyotrophic lateral sclerosis (ALS)

Cell culture studies suggest inhibiting TMX2 could help treat ALS caused by hexanucleotide repeat expansions in C9orf72. In a screen of a human acute myelogenous leukemia (AML) cell...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >